SRPL — Shreeram Proteins Income Statement
0.000.00%
- IN₹445.54m
- IN₹823.61m
- IN₹147.66m
Annual income statement for Shreeram Proteins, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,559 | 1,526 | 2,878 | 1,627 | 148 |
Cost of Revenue | |||||
Gross Profit | 128 | 111 | 179 | 146 | -45.6 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,493 | 1,478 | 2,758 | 1,532 | 238 |
Operating Profit | 65.6 | 47.5 | 120 | 95.3 | -90.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35.1 | 11 | 82.4 | 52.8 | -101 |
Provision for Income Taxes | |||||
Net Income After Taxes | 26.1 | 8.37 | 61.4 | 38.5 | -95.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 26.1 | 8.37 | 61.4 | 38.5 | -95.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 26.1 | 8.37 | 61.4 | 38.5 | -95.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.102 | 0.033 | 0.239 | 0.15 | -0.45 |